The most common neoplastic change in the pituitary gland is a prolactinoma. Its presence
leads to an increase in prolactin levels in the body, known as hyperprolactinemia. This tumor …

Background: Prolactinomas are the most common type of functional pituitary tumours. The
objective of this study was to determine demographic profile of patients with prolactinomas …

This review was published in Nature Reviews Endocrinology. It covers recent advances in
treatment of pituitary tumours secreting prolactin including long-term adverse effects of …

Aim Prolactinoma, a prolactin (PRL) secreting functioning pituitary tumor, is the most
common of all pituitary adenomas (PA) accounting for 40-60% and dopamine agonists (DA) …

Prolactinomas account for approximately 40% of all pituitary adenomas. Hyperprolactinemia
causes hypogonadism, infertility and galactorrhea. Macroprolactinomas may cause signs of …

Prolactin-secreting tumours (prolactinomas) are benign neoplasms constituting about 40
percent of all pituitary tumours. The incidence of these tumours varies with age and sex …

Background: Prolactinoma is the most common type of pituitary tumors. Primarily, it is treated
with dopamine agonists. If medical therapy cannot be tolerated or if it fails to reduce prolactin …

Prolactinomas are the most common pituitary tumor histotype, with microprolactinomas
being prevalent in women and macroprolactinomas in men. Hyperprolactinemia is among …

Background Along with the presence of the 2011 Endocrine Society Clinical Practice
Guidelines and numerous large-scale studies on the treatment of hyperprolactinemia of …

The authors present an update on the various treatment modalities and discuss
management strategies for prolactinomas. Prolactinomas are the most common type of …